로딩 중…
지수 로딩 중…
EyePoint Pharmaceuticals, Inc.
EYPT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$13.58+3.27%
2026-06-18
Price Chart
EyePoint Pharmaceuticals, Inc.+52.24%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.14B |
| Revenue | $8M |
| Net Income | $-272M |
| Total Assets | $288M |
| Net Assets | $230M |
| Value | |
| P/B | 4.94x |
| P/S | 149.52x |
| FCF Yield | -23.85% |
| Profitability | |
| ROE | -117.84% |
| ROA | -94.23% |
| Op. Margin | -3700.89% |
| Revenue Growth | -97.15% |
| Financial Health | |
| Debt Ratio | 25.06% |
| Total Debt | $20M |
| FCF | $-272M |
| Cash | $78M |
| Current Ratio | 6.66x |
| Performance | |
| 1Y Return | 52.24% |
| 1M Return | 14.89% |
| From 52W High | -28.94% |
| 1Y MDD | -39.26% |
| Trading | |
| Volume | 1,243,334 shares |
| Trading Value | $17M |
| Per Share | |
| EPS | $-2.79 |
| BPS | $3.69 |